Analyzing the role of the remaining GSK3 activity in head and neck squamous cell carcinoma, cells were incubated with 10 and 30 μM of the specific GSK3α/β inhibitor SB 216763, respectively. This evidence concerns the gene GSK3A and head and neck squamous cell carcinoma.